Fingerprint
Dive into the research topics of 'Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically